ArticleFrontiers in oncology2021

Anti-PD-1 Immunotherapy Combined With Stereotactic Body Radiation Therapy and GM-CSF as Salvage Therapy in a PD-L1-Positive Patient With Refractory Metastatic Thyroid Hürthle Cell Carcinoma: A Case Report and Literature Review.

Haihua He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.